Physician profile
Mune Gowda
NPI 1023121910
$10,749.71
in general payments reported to CMS, 2019-2025
34 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,146 · 2020: $2,753 · 2021: $1,287 · 2022: $803 · 2023: $1,208 · 2024: $1,536 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,435 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,434.60 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $1,648.86 | 2020 | |
| Integra Lifesciences Corporation | $1,471.11 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merz North America, INC. | $925.45 | 2019-2020 | |
| Mentor Worldwide LLC | $923.05 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $842.56 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Abbvie INC. | $528.34 | 2023-2025 | |
| Allergan, INC. | $456.63 | 2019-2022 | |
| Tepha INC | $418.71 | 2019 | |
| Kerecis Limited | $410.99 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Sientra, INC. | $361.80 | 2020-2021 | |
| Baxter Healthcare | $295.94 | 2021-2025 | Artiss |
| Tela Bio, INC. | $283.87 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kls-Martin L.P. | $182.92 | 2019-2020 | |
| Smith+Nephew, INC. | $170.98 | 2020-2024 | Pico 7, Renasys Touch |
| Solventum Corporation | $170.89 | 2025 | Prevena |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $153.05 | 2023-2024 | Trumatch, Na |
| Organogenesis INC. | $142.86 | 2024 | Puraply Franchise |
| Avita Medical Americas, LLC | $142.50 | 2024 | |
| Acell, INC. | $133.98 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $123.45 | 2021 | |
| Innovation Technologies INC | $122.77 | 2021 | |
| Apyx Medical Corporation | $115.28 | 2019-2020 | |
| Ethicon US, LLC | $114.77 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $107.54 | 2019 | |
| Polynovo North America LLC | $99.73 | 2022 | |
| Mimedx Group, INC. | $84.20 | 2025 | |
| Stryker Corporation | $74.41 | 2023 | Hydroset, Na |
| Revance Therapeutics, INC. | $71.79 | 2024 | Daxxify |
| Galderma Laboratories, L.P. | $61.28 | 2021-2023 | |
| Davol INC. | $35.51 | 2022 | |
| Aroa Biosurgery Incorporated | $35.07 | 2024 | |
| Motiva USA, LLC | $15.37 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $12.29 | 2022 | |
| Misonix INC | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mune Gowda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.